# The Effects of Atorvastatin Treatment in COPD Patients

> **NCT01748279** · PHASE4 · COMPLETED · sponsor: **Medical University of Bialystok** · enrollment: 18 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Formoterol
- **DRUG:** Lactose tablet

## Key facts

- **NCT ID:** NCT01748279
- **Lead sponsor:** Medical University of Bialystok
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01748279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01748279, "The Effects of Atorvastatin Treatment in COPD Patients". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT01748279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*